GNRSU down to $0.000001 on 18 Feb 2026: top loser on PNK, valuation signal

The GNRSU stock crashed to $0.000001 during market hours on 18 Feb 2026, marking it among the session’s top losers on the PNK exchange in the United States. Volume remained light at 145 shares while the previous close was $0.15, a drop of -99.9993%. This sharp move follows weak trading liquidity and lingering valuation questions in the Healthcare cannabis segment. We examine what drove the slide, key ratios, Meyka AI grading and a practical price outlook for investors watching GNRSU stock.

GNRSU stock market move and immediate drivers

GNRSU The Greenrose Holding Company Inc. (PNK) fell to $0.000001 from a previous close of $0.15, a one-day change of -99.9993%. Trading volume was 145 shares, well below typical active names, which amplified the price swing. The day low and high both printed at $0.000001, indicating extremely thin intraday liquidity and likely one or a few trade prints that moved the quote.

Company profile and sector context for GNRSU stock

The Greenrose Holding Company Inc. operates in Healthcare, focused on cannabis cultivation and processing, headquartered in Amityville, New York, United States. The company lists on PNK and reports 910 full time employees. The drug manufacturers specialty and generic industry facing regulatory and demand pressures has pressured small cap cannabis names and GNRSU stock in particular.

Key financials and valuation metrics for GNRSU stock

Reported company metrics show revenue per share TTM 1.58 and book value per share TTM 4.30, while shares outstanding are 12,853,627. Market data shows market cap near $13.00 using the current quote and earlier averages near $0.15. Ratios include a reported EPS 3.10 and a distorted P/E near zero driven by the micro-price. Current ratio is 0.21, debt to equity 1.57, and days of inventory on hand 439.24, which highlight liquidity and inventory risks.

Technical and trading picture behind the GNRSU stock collapse

Price averages of $0.15 for the 50- and 200-day suggest the recent print is far below trading norms. Low float and light volume make GNRSU stock vulnerable to outlier prints and quote updates. Short-term technical levels are unreliable here; order book depth and bid-ask gaps create execution risk for buyers and sellers.

Meyka grade, analyst context and risk factors for GNRSU stock

Meyka AI rates GNRSU with a score out of 100: 66.90 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, industry metrics, financial growth, key ratios, forecasts and analyst inputs. Key risks include extremely low liquidity, stretched valuation metrics due to micro-pricing, high inventory days and a thin market cap. Opportunities rest on operational recovery or a corporate action that restores tradability.

Valuation, price targets and GNRSU stock outlook

Meyka AI’s assessment models show scenarios rather than consensus targets. We present a cautious set of price targets: a downside floor at $0.000001, a base recovery target at $0.001, and a bullish scenario at $0.030. Those imply wide percentage moves from the current quote and reflect the stock’s low-liquidity profile. Any price target should be viewed through the lens of execution risk and potential corporate developments.

Final Thoughts

GNRSU stock’s collapse to $0.000001 on 18 Feb 2026 is primarily a liquidity and microstructure event amplified by a thin order book and low daily volume of 145 shares. Fundamental metrics show revenue per share 1.58 and book value per share 4.30, but short-term solvency measures such as current ratio 0.21 and days of inventory 439.24 flag operational stress. Meyka AI’s forecast model projects a 12-month baseline target of $0.001 from the current $0.000001, an implied upside of approximately 99,900.00%; forecasts are model-based projections and not guarantees. Given the Meyka grade (66.90, B, HOLD), we recommend that liquidity-seeking traders avoid size until quote depth improves and that longer-term investors await clearer operational updates or a corporate action that restores normal trading. For source documents and filings, refer to the company website and company profile; Meyka AI provides this as an AI-powered market analysis platform to help frame risks and scenarios.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.